@article{JTD2488,
author = {Isabelle Opitz},
title = {Management of malignant pleural mesothelioma—The European experience},
journal = {Journal of Thoracic Disease},
volume = {6},
number = {Suppl 2},
year = {2014},
keywords = {},
abstract = {Management of malignant pleural mesothelioma (MPM) remains a clinical challenge and the incidence of the disease will continue to increase worldwide. Several aspects of mesothelioma treatment are discussed controversially, in particular, regarding extend and best type of surgery, radiotherapy, and the role of neoadjuvant or adjuvant treatment. However, best survival data is reported from groups using multimodality treatment including macroscopic complete resection (MCR) achieved by either extrapleural pneumonectomy (EPP) or (extended) pleurectomy/decortication for patients qualifying from the tumor biology, stage, and patient’s risk factors. Several aspects have to be considered during surgery but morbidity and mortality have been reduced at experienced centres. The final analysis of extended selection algorithms is pending.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/2488}
}